查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830750

2025年全球器官移植市场报告

Cross-Species Organ Transplantation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，异种移植市场呈现强劲成长势头，从2024年的139.8亿美元成长至2025年的152亿美元，复合年增长率为8.7%。这段时期的成长归因于广泛的动物模型实验、新兴的生物伦理争论、慢性病盛行率的上升、猪-灵长类动物移植实验以及终末期器官衰竭导致的高死亡率。

异种移植市场规模预计在未来几年强劲成长，到2029年将达到209.5亿美元，复合年增长率为8.3%。预测期内的增长可归因于对可移植器官需求的不断增长、再生医学投资的不断增加、全球慢性肾臟病和肝臟疾病负担的加重、患者对移植可及性的倡导以及人类捐赠者的日益减少。这段时期的主要趋势包括基因编辑猪器官生产、与人体相容的基因组工程、人工智慧在器官匹配中的整合、血管3D生物列印、机器灌注和器官保存技术的进步，以及用于免疫抑制的奈米级药物传输系统。

异种器官移植，通常称为异种移植，是指将一个物种的活细胞、组织或整个器官移植到另一个物种，通常是从动物移植到人类。异种移植的主要目的是缓解需要移植的患者员工捐赠者短缺的问题。

异种移植的主要产品类型包括器官保存液、移植诊断产品和异种移植产品。器官保存液是特殊配製的液体，用于在运输过程中和移植前维持体外器官的活力。这些产品用于各种手术，包括肾臟、心臟、肝臟和肺移植，最终用户包括移植中心、医院和其他医疗机构。

2025年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了严重影响，特别是对关键医疗设备、诊断设备和药品的供应。医院和医疗机构面临进口手术器械、影像设备以及注射器和导管等消耗品成本上涨的问题。这些成本上涨给医疗保健预算带来了压力，导致一些医疗机构推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税阻碍了基本药品和医疗设备的生产，造成了供应链瓶颈。作为应对措施，该行业正在筹资策略多样化，尽可能促进本地生产，并倡导对紧急医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供异种移植市场统计数据，例如全球市场规模、区域份额、异种移植市场份额的竞争对手、详细的异种移植细分市场、市场趋势和商业机会，以及在异种移植行业取得成功所需的数据。异种移植市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯。

器官衰竭发病率的上升，尤其是创伤相关的多重器官衰竭，预计将在未来几年推动异种移植市场的成长。异种移植，也称为异种移植，涉及将器官从动物移植到人类，以解决捐赠器官的严重短缺问题。基因工程的广泛使用透过改造动物器官来减少免疫排斥并提高与人类接受者的相容性，在这一市场中发挥关键作用。例如，到 2023 年 7 月，美国基因与细胞治疗学会报告称，处于 2 期临床试验的基因疗法从第一季的 247 个增加到第二季的 260 个，凸显了基因工程应用的快速扩展。这一趋势正在推动能够解决人体器官短缺问题的异种移植解决方案的开发。

异种移植市场的公司越来越多地建立策略伙伴关係，以加速临床试验和监管核准。策略伙伴关係关係使公司能够利用彼此的专业知识和资源，从而在无需全面合併的情况下激发创新。例如，2025年2月，美国生物技术公司United Therapeutics与eGenesis合作，启动了FDA核准的基因改造猪肾移植人体临床试验。这些临床试验旨在为肾衰竭患者提供永续的替代方案，并解决全球捐赠器官短缺的问题。

2023年12月，联合治疗公司（United Therapeutics Corporation）收购了Miromatrix Medical, Inc.，进一步增强了其异种移植能力。 Miromatrix Medical, Inc.是一家专注于透过去细胞和再细胞化技术进行生物工程器官开发的美国公司。此次收购增强了联合治疗公司开发结合基因和生物工程方法的先进异种移植解决方案的能力，从而扩大了可移植器官的可用性。

异种器官移植市场由提供临床前和临床异种移植服务、器官和组织配型、移植后护理和监测以及再生和生物工程解决方案等服务的营业单位所获得的收益构成。市场价值包括服务供应商销售的或包含在其服务产品中的任何相关商品的价值。异种器官移植市场还包括免疫抑制剂、活组织以及器官支架或基质的销售。该市场的价值是指“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球异种移植：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球异种移植市场：成长率分析
  • 全球异种器官移植市场表现：规模与成长，2019-2024
  • 全球异种器官移植市场预测：规模与成长，2024-2029年，2034年
  • 全球异种移植：总潜在市场（TAM）

第六章 市场细分

  • 全球异种移植市场（依产品类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 器官保存解决方案
  • 移植诊断
  • 芝诺产品
  • 其他产品类型
  • 全球异种移植市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 肾
  • 心
  • 肝
  • 肺
  • 其他用途
  • 全球异种移植市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 移植中心
  • 医院
  • 其他最终用户
  • 全球异种移植市场：依器官保存解决方案细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 低温机灌注 (HMP) 解决方案
  • 常温机械灌注（NMP）溶液
  • 静态冷藏保管（SCS）解决方案
  • 氧合灌注液
  • 全球异种器官移植市场：依移植诊断（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 组织分型
  • 交叉配对试验
  • 分子分型（DNA检测）
  • 免疫监测试验
  • 全球异种移植市场：依产品类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 基因改造捐赠器官
  • 去细胞器官支架
  • 异源细胞治疗
  • 异种移植的免疫抑制治疗
  • 全球异种移植市场：按类型细分、按类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 器官运输装置
  • 器官提取和保存设备
  • 移植手术器械
  • 移植后监测装置

第七章 区域和国家分析

  • 全球异种器官移植市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球异种器官移植市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 异种移植市场：竞争格局
  • 异种移植市场：公司简介
    • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-la Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Optipharm Co Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Astellas Pharma Inc.
  • United Therapeutics Corporation
  • TransMedics Group Inc.
  • Artivion Inc.
  • eGenesis Inc.
  • Organ Recovery Systems Inc.
  • OrganOX Ltd
  • Paragonix Technologies Inc.
  • Qihan Biotech
  • PorMedTec Co.
  • XenoTheraputics Inc.
  • Makana Therapeutics Inc.
  • Preservation Solutions Inc.
  • Nzeno Ltd
  • Infigen Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年异种移植市场：提供新机会的国家
  • 2029年异种移植市场：细分领域带来新机会
  • 异种移植市场2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37738

Cross-species organ transplantation, commonly referred to as xenotransplantation, involves transferring living cells, tissues, or whole organs from one species to another, most often from animals to humans. The primary aim of xenotransplantation is to alleviate the shortage of human donor organs for patients requiring transplants.

The main product types in cross-species organ transplantation include organ preservation solutions, transplant diagnostics, xeno products, and others. Organ preservation solutions are specially formulated liquids designed to maintain organ viability outside the body during transport and prior to transplantation. These products are applied in a variety of procedures, including kidney, heart, liver, and lung transplants, and are utilized by end users such as transplant centers, hospitals, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cross-species organ transplantation market research report is one of a series of new reports from The Business Research Company that provides cross-species organ transplantation market statistics, including cross-species organ transplantation industry global market size, regional shares, competitors with a cross-species organ transplantation market share, detailed cross-species organ transplantation market segments, market trends and opportunities, and any further data you may need to thrive in the cross-species organ transplantation industry. The cross-species organ transplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cross-species organ transplantation market size has grown strongly in recent years. It will grow from $13.98 billion in 2024 to $15.20 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be attributed to extensive animal model experimentation, the emergence of bioethical debates, the increasing prevalence of chronic diseases, experimental pig-to-primate transplants, and high mortality rates from end-stage organ failure.

The cross-species organ transplantation market size is expected to see strong growth in the next few years. It will grow to $20.95 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising demand for transplantable organs, increasing investments in regenerative medicine, the global burden of chronic kidney and liver diseases, patient advocacy for transplant access, and the declining availability of human donors. Major trends during this period include the production of gene-edited pig organs, human-compatible genome engineering, integration of artificial intelligence in organ matching, 3D bioprinting of vascular structures, advancements in machine perfusion and organ preservation technologies, and nanoscale drug delivery systems for immunosuppression.

The rising incidence of organ failure, particularly trauma-related multiple organ failure, is expected to drive the growth of the cross-species organ transplantation market in the coming years. Cross-species organ transplantation, also known as xenotransplantation, involves transplanting organs from animals into humans to address critical shortages of donor organs. The growing adoption of genetic engineering plays a pivotal role in this market by enabling the modification of animal organs to reduce immune rejection, making them more compatible for human recipients. For example, by July 2023, the American Society of Gene & Cell Therapy reported an increase in gene therapies in Phase II clinical trials from 247 in the first quarter to 260 in the second quarter, highlighting the rapid expansion of genetic engineering applications. This trend supports the development of xenotransplantation solutions capable of addressing the shortage of human organs.

Companies in the cross-species organ transplantation market are increasingly forming strategic partnerships to accelerate clinical trials and regulatory approvals. Strategic partnerships allow organizations to leverage each other's expertise and resources, fostering innovation without requiring full mergers. For instance, in February 2025, United Therapeutics, a US-based biotechnology company, partnered with eGenesis to begin FDA-approved clinical trials for genetically modified pig kidney transplants in humans. These trials aim to provide a sustainable alternative for patients with kidney failure, addressing the global donor organ shortage.

In December 2023, United Therapeutics Corporation further strengthened its xenotransplantation capabilities by acquiring Miromatrix Medical Inc., a US-based company specializing in bioengineered organs through decellularization and recellularization techniques. This acquisition enhances United Therapeutics' ability to develop advanced cross-species organ transplantation solutions, combining genetic engineering and bioengineering approaches to expand the availability of transplantable organs.

Major players in the cross-species organ transplantation market are Pfizer Inc, F. Hoffmann-la Roche Ltd, Sanofi SA, Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc.

North America was the largest region in the cross-species organ transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cross-species organ transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cross-species organ transplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cross-species organ transplantation market consists of revenues earned by entities by providing services such as preclinical and clinical xenotransplantation services, organ and tissue matching, post-transplant care and monitoring, and regenerative and bioengineered solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The cross-species organ transplantation market also includes sales of immunosuppressive drugs, bioengineered tissues, and organ scaffolds or matrices. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cross-Species Organ Transplantation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cross-species organ transplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cross-species organ transplantation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cross-species organ transplantation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Organ Preservation Solution; Transplant Diagnostics; Xeno Products; Other Product Types
  • 2) By Application: Kidney; Heart; Liver; Lung; Other Applications
  • 3) By End-User: Transplant Centers; Hospitals; Other End-Users
  • Subsegments:
  • 1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions; Normothermic Machine Perfusion (NMP) Solutions; Static Cold Storage (SCS) Solutions; Oxygenated Perfusion Solutions
  • 2) By Transplant Diagnostics: Histocompatibility Testing; Crossmatching Tests; Molecular Typing (DNA-based Testing); Immunological Monitoring Assays
  • 3) By Xeno Products: Genetically Engineered Donor Organs; Decellularized Organ Scaffolds; Xenogeneic Cellular Therapies; Immunosuppressive Regimens For Xenotransplants
  • 4) By Other Product Types: Organ Transport Devices; Organ Recovery and Preservation Equipment; Surgical Instruments For Transplantation; Post-Transplant Monitoring Devices
  • Companies Mentioned: Pfizer Inc; F. Hoffmann-la Roche Ltd; Sanofi SA; Novartis AG; Optipharm Co Ltd; Astellas Pharma Inc.; United Therapeutics Corporation; TransMedics Group Inc.; Artivion Inc.; eGenesis Inc.; Organ Recovery Systems Inc.; OrganOX Ltd; Paragonix Technologies Inc.; Qihan Biotech; PorMedTec Co.; XenoTheraputics Inc.; Makana Therapeutics Inc.; Preservation Solutions Inc.; Nzeno Ltd; Infigen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cross-Species Organ Transplantation Market Characteristics

3. Cross-Species Organ Transplantation Market Trends And Strategies

4. Cross-Species Organ Transplantation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cross-Species Organ Transplantation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cross-Species Organ Transplantation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cross-Species Organ Transplantation Market Growth Rate Analysis
  • 5.4. Global Cross-Species Organ Transplantation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cross-Species Organ Transplantation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cross-Species Organ Transplantation Total Addressable Market (TAM)

6. Cross-Species Organ Transplantation Market Segmentation

  • 6.1. Global Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organ Preservation Solution
  • Transplant Diagnotics
  • Xeno Products
  • Other Product Types
  • 6.2. Global Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney
  • Heart
  • Liver
  • Lung
  • Other Applications
  • 6.3. Global Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transplant Centers
  • Hospitals
  • Other End-Users
  • 6.4. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Organ Preservation Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hypothermic Machine Perfusion (HMP) Solutions
  • Normothermic Machine Perfusion (NMP) Solutions
  • Static Cold Storage (SCS) Solutions
  • Oxygenated Perfusion Solutions
  • 6.5. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Transplant Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Histocompatibility Testing
  • Crossmatching Tests
  • Molecular Typing (DNA-based Testing)
  • Immunological Monitoring Assays
  • 6.6. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Xeno Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetically Engineered Donor Organs
  • Decellularized Organ Scaffolds
  • Xenogeneic Cellular Therapies
  • Immunosuppressive Regimens For Xenotransplants
  • 6.7. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Other Types, By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organ Transport Devices
  • Organ Recovery And Preservation Equipment
  • Surgical Instruments For Transplantation
  • Post-Transplant Monitoring Devices

7. Cross-Species Organ Transplantation Market Regional And Country Analysis

  • 7.1. Global Cross-Species Organ Transplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cross-Species Organ Transplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cross-Species Organ Transplantation Market

  • 8.1. Asia-Pacific Cross-Species Organ Transplantation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cross-Species Organ Transplantation Market

  • 9.1. China Cross-Species Organ Transplantation Market Overview
  • 9.2. China Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cross-Species Organ Transplantation Market

  • 10.1. India Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cross-Species Organ Transplantation Market

  • 11.1. Japan Cross-Species Organ Transplantation Market Overview
  • 11.2. Japan Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cross-Species Organ Transplantation Market

  • 12.1. Australia Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cross-Species Organ Transplantation Market

  • 13.1. Indonesia Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cross-Species Organ Transplantation Market

  • 14.1. South Korea Cross-Species Organ Transplantation Market Overview
  • 14.2. South Korea Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cross-Species Organ Transplantation Market

  • 15.1. Western Europe Cross-Species Organ Transplantation Market Overview
  • 15.2. Western Europe Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cross-Species Organ Transplantation Market

  • 16.1. UK Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cross-Species Organ Transplantation Market

  • 17.1. Germany Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cross-Species Organ Transplantation Market

  • 18.1. France Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cross-Species Organ Transplantation Market

  • 19.1. Italy Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cross-Species Organ Transplantation Market

  • 20.1. Spain Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cross-Species Organ Transplantation Market

  • 21.1. Eastern Europe Cross-Species Organ Transplantation Market Overview
  • 21.2. Eastern Europe Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cross-Species Organ Transplantation Market

  • 22.1. Russia Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cross-Species Organ Transplantation Market

  • 23.1. North America Cross-Species Organ Transplantation Market Overview
  • 23.2. North America Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cross-Species Organ Transplantation Market

  • 24.1. USA Cross-Species Organ Transplantation Market Overview
  • 24.2. USA Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cross-Species Organ Transplantation Market

  • 25.1. Canada Cross-Species Organ Transplantation Market Overview
  • 25.2. Canada Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cross-Species Organ Transplantation Market

  • 26.1. South America Cross-Species Organ Transplantation Market Overview
  • 26.2. South America Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cross-Species Organ Transplantation Market

  • 27.1. Brazil Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cross-Species Organ Transplantation Market

  • 28.1. Middle East Cross-Species Organ Transplantation Market Overview
  • 28.2. Middle East Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cross-Species Organ Transplantation Market

  • 29.1. Africa Cross-Species Organ Transplantation Market Overview
  • 29.2. Africa Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cross-Species Organ Transplantation Market Competitive Landscape And Company Profiles

  • 30.1. Cross-Species Organ Transplantation Market Competitive Landscape
  • 30.2. Cross-Species Organ Transplantation Market Company Profiles
    • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-la Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Optipharm Co Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Cross-Species Organ Transplantation Market Other Major And Innovative Companies

  • 31.1. Astellas Pharma Inc.
  • 31.2. United Therapeutics Corporation
  • 31.3. TransMedics Group Inc.
  • 31.4. Artivion Inc.
  • 31.5. eGenesis Inc.
  • 31.6. Organ Recovery Systems Inc.
  • 31.7. OrganOX Ltd
  • 31.8. Paragonix Technologies Inc.
  • 31.9. Qihan Biotech
  • 31.10. PorMedTec Co.
  • 31.11. XenoTheraputics Inc.
  • 31.12. Makana Therapeutics Inc.
  • 31.13. Preservation Solutions Inc.
  • 31.14. Nzeno Ltd
  • 31.15. Infigen Inc.

32. Global Cross-Species Organ Transplantation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cross-Species Organ Transplantation Market

34. Recent Developments In The Cross-Species Organ Transplantation Market

35. Cross-Species Organ Transplantation Market High Potential Countries, Segments and Strategies

  • 35.1 Cross-Species Organ Transplantation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cross-Species Organ Transplantation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cross-Species Organ Transplantation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer